Bellicum Pharmaceuticals' Grant - II Round

Bellicum Pharmaceuticals raised a round of funding on March 08, 2012. Investors include Cancer Prevention and Research Institute of Texas.

Bellicum Pharmaceuticals is developing safer and more effective cell therapies to treat cancers and other chronic and life-threatening diseases. The Company's cell-based therapies incorporate either t…

Articles about Bellicum Pharmaceuticals' Grant - II Round: